An inspiring look at AKI (NGAL versus the rest)

Even if it does not look like the Author is crowning NGAL as the winner  as the “one-and-only-biomarker” for AKI:)

One of the reasons for this is the large variation on cut-off’s used… well – that we can  change easily – in a jiffy 🙂 … it’s just a matter of  Alere/abbott et al using the RIGHT cutoff-value (250 ng/ml)

Anyway – the most important point made in the Presentation is;  that in spite of 40 years of intense research,  researchers and scientists are still struggling to expand the “window of opportunity” for satisfactory treatment of AKI.. – Because – as we all know  Therapies will only work if the patient is diagnosed rapidly and correctly

Read the article on AKI here.